Insights

You learn a lot when you spend months reporting on a given issue or community, as our fellows can attest. Whether you’re embarking on a big new story or seeking to go deeper on a given issue, it pays to learn from those who’ve already put in the shoe leather and crunched the data. In these essays and columns, our community of journalists steps back from the notebooks and tape to reflect on key lessons, highlight urgent themes, and offer sage advice on the essential health stories of the day. 

Author(s)
By William Heisel

<p>Andrew Schneider is one of the country's most accomplished investigative journalists. His work has won not just <a href="http://www.pulitzer.org/awards/1987">one</a&gt;, but <a href="http://www.pulitzer.org/awards/1986">two</a&gt; Pulitzer Prizes, and countless other awards. I had the privilege of meeting him when both of us were finalists for the <a href="http://www.hks.harvard.edu/presspol/news_events/archive/2001/goldsmith_… Prize</a> for Investigative Reporting at Harvard. My team lost. So did his.

Author(s)
By William Heisel

<p>If you, like me, were wondering how a guy like Dr. Conrad Murray, who had not bothered
keeping up with his studies enough to continue his certification as a cardiologist, could become the personal physician to the King of Pop, it's instructive to look at Dr. Jagat Narula.</p>

<p>Most of you won't know that name, but his career illuminates the gap between what the public expects when they see "Dr." in front of a person's name and what is often the reality.</p>

Author(s)
By Barbara Feder Ostrov

<p>The CDC today launched a Web-based environmental public health tracking network that could be a fantastic resource for journalists looking for stories in their state or county.</p>

<p>I say "could be" because right now, the system is frustratingly slow to use, even with a decent Internet connection. </p>

Author(s)
By Angilee Shah

<p>The illegal use and sale of prescription drugs is not just a topic for Michael Jackson headlines. A <a href="http://www.usdoj.gov/dea/concern/prescription_drug_fact_sheet.html">fact sheet from the U.S. Drug Enforcement Administration</a> says that nearly 7 million Americans are addicted to prescription drugs. The DEA says that abusers get their drugs from "'doctor-shopping,' traditional drug-dealing, theft from pharmacies or homes, illicitly acquiring prescription drugs via the Internet, and from friends or relatives."</p>

Author(s)
By William Heisel

<p>Think about what it takes to obtain a medical license. Some states' licensing boards will rubber stamp a license from another state but others, like California's, require a lot of hoops.</p> <p>Then consider the case of Dr. Gregory Burnham Camp, who had licenses in California (No. 34329), Ohio (35-028433), North Carolina (36156) and Massachusetts. Why so many states?</p>

Author(s)
By William Heisel

<p>Misadministration. When a physician has made a horrible mistake with wide-ranging ramifications, the terms "negligence," "malpractice" even "incompetence" might come to mind. Now this wonderful euphemism glides onto the scene, draping the wreckage in a filigree of blamelessness, warding off trial lawyers and investigative journalists. </p>

Author(s)
By Barbara Feder Ostrov

<p>The Washington Post's newsroom is in an uproar today after the political news website Politico.com broke a shocking <a href="http://www.politico.com/news/stories/0709/24441.html">story</a>: </p>

<p>"For $25,000 to $250,000, The Washington Post has offered lobbyists and association executives off-the-record, nonconfrontational access to "those powerful few": Obama
administration officials, members of Congress, and - at first - even the paper's own reporters and editors."</p>

Author(s)
By Barbara Feder Ostrov

<p>A new Institute of Medicine <a href="http://www.nap.edu/catalog.php?record_id=12648#toc">report</a&gt; offers some excellent fodder for stories on "comparative effectiveness research," which examines whether and why some medical treatments are more effective than others. </p>

<p>You'll be hearing a lot about the comparative effectiveness buzzword as the national health reform debate unfolds, because it's seen as crucial in in lowering health costs. Why spend money on drug-eluting stents for heart disease, for example, if plain old stents might just keep people alive longer? </p>